{"id":"W3169669455","doi":"10.1200/jco.2021.39.15_suppl.tps2071","title":"A phase 1/2 study of selinexor in combination with standard of care therapy for newly diagnosed or recurrent glioblastoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Karyopharm Therapeutics","keywords":"Medicine; Temozolomide; Oncology; Internal medicine; Radiation therapy; Phases of clinical research; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001525987,0.002682558,0.002206635,0.0009652693,0.0004333338,0.001017031,0.00148307,0.001749229,0.006069238],"category_scores_gemma":[0.0007614136,0.0008777133,0.001617293,0.0005130224,0.001124454,0.0009345681,0.0003613407,0.00338575,0.001368366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001262564,"about_ca_system_score_gemma":0.002329074,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002100454,"about_ca_topic_score_gemma":0.005415793,"domain_scores_codex":[0.9995509,0.0001919085,0.00001622111,0.00007312073,0.00005466852,0.0001131633],"domain_scores_gemma":[0.999534,0.00004556681,0.0000872481,0.00003991835,0.00004642062,0.0002468431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5512525,0.2457892,0.004118246,0.001842702,0.002260059,0.0006200277,0.0003959064,0.003184626,0.057772,0.0006673753,0.01440063,0.1176968],"study_design_scores_gemma":[0.5248136,0.461013,0.004833633,0.00005395388,0.0004486182,0.00035853,0.00006986827,0.001202199,0.003409416,0.0002460566,0.003510193,0.00004090546],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792436,0.002378368,0.001139867,0.001048438,0.0003702191,0.0103512,0.002133794,0.0002898816,0.003044709],"genre_scores_gemma":[0.9585567,0.005014331,0.00504073,0.002656852,0.0003469826,0.01437615,0.005657102,0.0001270579,0.00822406],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006069238,"threshold_uncertainty_score":0.02030367,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04485776485031373,"score_gpt":0.4307023348064595,"score_spread":0.3858445699561458,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}